Patients’ preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer

Axel Mühlbacher () and Susanne Bethge

The European Journal of Health Economics, 2015, vol. 16, issue 6, 657-670

Abstract: Preference measurement showed “progression-free survival” and “tumor-associated symptoms” had a significant influence on the treatment decision. Subgroup analysis revealed that the importance of “progression-free survival” increases with increased therapy experience. Based on the presented results therapies can be designed, assessed and chosen on the basis of patient-oriented findings. As such, more effective and efficient care of patients can be achieved and benefits increased. Copyright The Author(s) 2015

Keywords: Discrete-choice experiment; Non-small-cell lung cancer; Patient preferences; Patient-relevant treatment attributes; I10; I15; D700 (search for similar items in EconPapers)
Date: 2015
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://hdl.handle.net/10.1007/s10198-014-0622-4 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:16:y:2015:i:6:p:657-670

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-014-0622-4

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().